Perth Children's Hospital

Perth, Australia

Description

The Department of Paediatric and Adolescent Oncology/Haematology at Perth Children’s Hospital (PCH) provides the sole state-wide service in Western Australia for the diagnosis and management of children and adolescents with cancer and blood disorders. The unit is composed of a multi-disciplinary team, with medical and psychosocial expertise in providing holistic inpatient, same day and outpatient care for children and young people with cancer, malignant blood disorders, non-malignant blood disorders such as haemophilia, and haematopoietic stem cell transplantation as a continuum of care from diagnosis to outcome.

Clinical trials are embedded in childhood cancer treatment at PCH. These trials include front-line treatment for many types of childhood cancers, studies aimed at determining the underlying biology of these diseases, and trials involving new and emerging treatments, supportive care, and survivorship. This provides children and adolescents with cancer access to state of the art and cutting edge therapies, as well as advanced molecular testing. The Paediatric and Adolescent Oncology/Haematology Unit at PCH currently (as of September 2019) has 86 open clinical trials, including therapeutic (23 phase III, 26 phase I/II), 19 biology/registries and 16 late effects trials (which focus on long-term survivors).

Contact information

 

Department of Paediatric and Adolescent Oncology/Haematology

Perth Children’s Hospital 

15 Hospital Avenue,

Nedlands, Perth,

Western Australia, Australia

WA 6009

Ph: (08) 64560241

E: nick.gottardo@health.wa.gov.au

Team

Principal Investigator

Nick Gottardo, MB ChB FRACP PhD

Consultant Paediatric Oncologist/Neuro-oncologist
Prof Nick Gottardo is Head of the Paediatric and Adolescent Oncology/Haematology Department at Perth Children’s Hospital, Western Australia and a Paediatric Oncologist and Neuro-Oncologist. He co-leads the Brain Tumour Research Programme at the Telethon Kids Institute, which focuses on providing laboratory evidence that will more accurately inform new paediatric brain cancer clinical trials. He is the Deputy Chair on the Australian and New Zealand Children’s Haematology/Oncology Group (ANZCHOG) Executive and he also chairs the ANZCHOG Central Nervous System (CNS) Tumour Group. He leads the Children’s Oncology Group’s front-line clinical trial for WNT-driven Medulloblastoma (ACNS1422) and the Australian AIM-BRAIN PROject (Access to Innovative Molecular diagnostic PROfiling) for CNS tumours.

Nick Gottardo, MB ChB FRACP PhD

Consultant Paediatric Oncologist/Neuro-oncologist